Afya Limited Stock Price, News & Analysis

Afya Limited (AFYA) has announced its Annual General Meeting (AGM) scheduled for June 24, 2025, at 10:00 a.m. BRT, to be held both physically in Nova Lima, Brazil, and virtually. The meeting agenda includes approval of 2024 financial statements and re-appointment of four independent directors: João Paulo Seibel de Faria, Vanessa Claro Lopes, Miguel Filisbino Pereira de Paula, and Marcelo Ken Suhara, each for two-year terms. The record date is set for May 14, 2025. Shareholders can participate virtually via a secure link and are encouraged to vote either in person or by proxy. The Board recommends shareholders vote "FOR" all resolutions.

Afya Limited (NASDAQ: AFYA), Brazil's leading medical education and practice solutions provider, has announced a change in its independent auditing firm. The company's board of directors, following the audit committee's recommendation, has approved KPMG Auditores Independentes Ltda. to replace Ernst & Young Auditores Independentes S/S Ltda. as its independent registered public accounting firm. KPMG will begin its auditing services with the review of Afya's quarterly information for Q2 2025.

Afya Limited (NASDAQ: AFYA) reported strong Q1 2025 financial results with significant growth across key metrics. Net Revenue increased 16.4% YoY to R$936.4 million, while Adjusted EBITDA grew 23.7% YoY to R$492.0 million with a margin expansion of 300 bps to 52.5%. Net Income rose 23.4% YoY to R$257.0 million. The company maintained high occupancy rates in medical schools and successfully integrated recent acquisitions, including Unidom. Afya's ecosystem reached over 317,000 users, and the company received an upgraded credit rating to AAA.br from Moody's. The acquisition of Funic added 60 medical seats, bringing total approved seats to 3,653. The company reaffirmed its 2025 guidance, projecting net revenue between R$3,670-3,770 million and Adjusted EBITDA of R$1,620-1,720 million.

Afya Limited (NASDAQ: AFYA) has completed the acquisition of FACULDADE ÚNICA DE CONTAGEM (FUNIC) for R$100 million. The acquisition adds 60 medical school seats to Afya's portfolio, with operations expected to begin in H2 2025. The payment structure includes R$60 million paid in cash and R$40 million to be paid in three annual CDI-adjusted installments. A contingent consideration provides for an additional payment of R$1 million per seat for up to 60 additional medical school seats if approved by MEC within 36 months. The pre-operational facility is located in Contagem, near Belo Horizonte, Minas Gerais. At full maturity in 2030, Afya projects an EV/EBITDA of 3.3x post-synergies, with expected Net Revenues of R$52.4 million entirely from medical education.

Afya (NASDAQ: AFYA) reported strong financial results for Q4 and full-year 2024. Fourth quarter highlights include:

- Net Revenue up 16.3% YoY to R$849.0 million
- Adjusted EBITDA increased 26.7% YoY to R$366.0 million
- Net Income grew 51.4% YoY to R$154.3 million

Full-year 2024 achievements:

• Net Revenue reached R$3,304.3 million (+14.9% YoY)
• Adjusted EBITDA of R$1,455.6 million (+24.9% YoY)
• Net Income of R$648.9 million (+60.1% YoY)
• Operating Cash Conversion ratio of 102.2%

The company announced its first dividend distribution, with a 20% payout of 2024 net income (R$129.8 million). Afya expanded its medical education footprint through acquisitions and seat additions, reaching 3,653 approved medical school seats. The ecosystem now serves over 313,000 users.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group, has announced its first-ever cash dividend distribution of R$129.8 million, representing 20% of the company's R$648.9 million consolidated net income for 2024.

The dividend per share is set at R$1.348923, payable in U.S. dollars on April 4, 2025, to shareholders of record as of March 26, 2025. The payment will be converted using the Brazilian Central Bank's exchange rate of R$/USD 5.8131 published on March 13, 2025.

CFO Luis Blanco emphasized that this distribution demonstrates the company's commitment to shareholder value while maintaining their growth guidance.

Afya (Nasdaq: AFYA; B3: A2FY34) has entered into a share purchase agreement to acquire 100% of Faculdade Única de Contagem (FUNIC) through its subsidiary Afya Participações S.A. The acquisition adds 60 medical school seats in Contagem, Minas Gerais, marking Afya's fifth medical school in the state. The total purchase price is R$ 100 million, with R$ 60 million paid in cash at closing and R$ 40 million in three annual CDI-adjusted installments.

The deal includes potential for 60 additional seats if approved by MEC within 36 months, with R$ 1 million payment per granted seat. At full maturity in 2030, Afya expects an EV/EBITDA of 3.3x with projected Net Revenues of R$ 52.4 million from Medicine operations.

Afya reported strong financial results for Q3 2024, with net revenue increasing 16.3% YoY to R$841.2 million. The company's Adjusted EBITDA grew 25.0% YoY to R$347.9 million, with margin expansion of 290 bps to 41.4%. Net Income rose 26.4% YoY to R$124.1 million. For the nine-month period, net revenue increased 14.4% to R$2,455.3 million, while Adjusted EBITDA grew 24.3% to R$1,089.6 million. The company completed the acquisition of Unidom, adding 300 medical seats, and received authorization for 80 additional seats at UNIMA and 10 seats at Unigranrio, bringing total approved seats to 3,593.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group and medical practice solutions provider, has announced it will release its third-quarter and nine months 2024 financial results on November 13th, 2024, after market close. The company will host a conference call and webcast at 05:00 pm EST to discuss the results. Investors can access the webcast through Afya's Investor Relations website and participate via various dial-in numbers provided for Brazil and United States.